Abstract
Protein mobility, chromatin movement and the formation of molecular assemblies in the cell nucleus have, until fairly recently, been viewed in a pseudo-static light, even though the dynamics of other cellular regions have been partly, or wholly understood for a number of years. The new science that has recently emerged on nuclear kinetics reveals a nucleus that has mobile proteins, dynamic intra-nuclear compartments and chromatin that is far from being static. This new knowledge has given scientists a deeper understanding of transcription, translation and the cell cycle. With these fundamentals of nuclear operation, has come a greater understanding of genetics and genetic diseases – so much so that, by way of example, diseases of chromatin have as a category, made significant advances. Whilst certain questions relating to protein mobility, chromatin movement and the formation of molecular assemblies have been answered, many key questions still remain. Those remaining questions have now started to be answered by technological developments. This review marshals the latest scientific evidence on the molecular kinetics of the nucleus that has arisen from a number of recent, elegant experiments.
Keywords: Dynamics, protein dynamics, chromatin dynamics, residence time, surface profile
Current Chemical Biology
Title: Molecular Kinetics and Targeting Within the Nucleus
Volume: 2 Issue: 3
Author(s): Christopher M. Wood
Affiliation:
Keywords: Dynamics, protein dynamics, chromatin dynamics, residence time, surface profile
Abstract: Protein mobility, chromatin movement and the formation of molecular assemblies in the cell nucleus have, until fairly recently, been viewed in a pseudo-static light, even though the dynamics of other cellular regions have been partly, or wholly understood for a number of years. The new science that has recently emerged on nuclear kinetics reveals a nucleus that has mobile proteins, dynamic intra-nuclear compartments and chromatin that is far from being static. This new knowledge has given scientists a deeper understanding of transcription, translation and the cell cycle. With these fundamentals of nuclear operation, has come a greater understanding of genetics and genetic diseases – so much so that, by way of example, diseases of chromatin have as a category, made significant advances. Whilst certain questions relating to protein mobility, chromatin movement and the formation of molecular assemblies have been answered, many key questions still remain. Those remaining questions have now started to be answered by technological developments. This review marshals the latest scientific evidence on the molecular kinetics of the nucleus that has arisen from a number of recent, elegant experiments.
Export Options
About this article
Cite this article as:
Wood M. Christopher, Molecular Kinetics and Targeting Within the Nucleus, Current Chemical Biology 2008; 2 (3) . https://dx.doi.org/10.2174/2212796810802030229
DOI https://dx.doi.org/10.2174/2212796810802030229 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Application of Pharmacogenomic Approaches in the Study of Drug Response in Complex Diseases
Current Pharmacogenomics γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry Bioactive Chromone Derivatives – Structural Diversity
Current Bioactive Compounds HOX Genes as Potential Markers of Circulating Tumour Cells
Current Molecular Medicine Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
Current Cancer Drug Targets Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Current Pharmaceutical Design Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Development Course and an Application Strategy for Induced Pluripotent Stem Cells in Regenerative Medicine
Current Stem Cell Research & Therapy In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Current Medicinal Chemistry Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Current Drug Therapy Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with 211At
Current Radiopharmaceuticals Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate
Letters in Drug Design & Discovery Clinical Experience with Antiangiogenic Therapy in Leukemia
Current Cancer Drug Targets Delineation of Current Development of Antimitotic Compounds Targeting Cytoskeletal Protein Tubulin and Microtubule in the Cancer Therapy
Current Chemical Biology Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)
Current Cancer Therapy Reviews Palifermin in theManagement of Mucositis in Hematological Malignancies: Current Evidences and Future Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry Propofol Protects Against TNF-α-induced Blood-brain Barrier Disruption via the PIM-1/eNOS/NO Pathway
Current Neurovascular Research Involvement of Cannabinoids in Cellular Proliferation
Mini-Reviews in Medicinal Chemistry Pharmaceutical Applications of the Benzylisoquinoline Alkaloids from Argemone mexicana L.
Current Topics in Medicinal Chemistry Metabolomics: A Revolution for Novel Cancer Marker Identification
Combinatorial Chemistry & High Throughput Screening